556 related articles for article (PubMed ID: 17173506)
21. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.
Keren A; Syrris P; McKenna WJ
Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):158-68. PubMed ID: 18227814
[TBL] [Abstract][Full Text] [Related]
22. The pathology of hypertrophic cardiomyopathy.
Hughes SE
Histopathology; 2004 May; 44(5):412-27. PubMed ID: 15139989
[TBL] [Abstract][Full Text] [Related]
23. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
[TBL] [Abstract][Full Text] [Related]
24. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.
Kabaeva ZT; Perrot A; Wolter B; Dietz R; Cardim N; Correia JM; Schulte HD; Aldashev AA; Mirrakhimov MM; Osterziel KJ
Eur J Hum Genet; 2002 Nov; 10(11):741-8. PubMed ID: 12404107
[TBL] [Abstract][Full Text] [Related]
25. [Clinical relevance of genetic testing in hypertrophic cardiomyopathy].
Girolami F; Bardi S; Berti L; Cecchi F; Servettini E; Tomberli B; Torricelli F; Olivotto I
Recenti Prog Med; 2011 Dec; 102(12):486-93. PubMed ID: 22258194
[TBL] [Abstract][Full Text] [Related]
26. Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?
Brito D; Madeira H
Rev Port Cardiol; 2005 Sep; 24(9):1137-46. PubMed ID: 16335287
[TBL] [Abstract][Full Text] [Related]
27. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
[TBL] [Abstract][Full Text] [Related]
28. Mutation screening of the PTPN11 gene in hypertrophic cardiomyopathy.
Limongelli G; Hawkes L; Calabro R; McKenna WJ; Syrris P
Eur J Med Genet; 2006; 49(5):426-30. PubMed ID: 16488201
[TBL] [Abstract][Full Text] [Related]
29. [Hypertrophic cardiomyopathies].
Charron P; Komajda M
Arch Mal Coeur Vaiss; 2003 Nov; 96(11):1042-7. PubMed ID: 14694779
[TBL] [Abstract][Full Text] [Related]
30. Cardiac magnetic field map topology quantified by Kullback-Leibler entropy identifies patients with hypertrophic cardiomyopathy.
Schirdewan A; Gapelyuk A; Fischer R; Koch L; Schütt H; Zacharzowsky U; Dietz R; Thierfelder L; Wessel N
Chaos; 2007 Mar; 17(1):015118. PubMed ID: 17411275
[TBL] [Abstract][Full Text] [Related]
31. Hypertrophic cardiomyopathy: etiology, diagnosis, and treatment.
Ramaraj R
Cardiol Rev; 2008; 16(4):172-80. PubMed ID: 18562807
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond.
Kimura A
J Hum Genet; 2010 Feb; 55(2):81-90. PubMed ID: 20075948
[TBL] [Abstract][Full Text] [Related]
33. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling.
Ingles J; Doolan A; Chiu C; Seidman J; Seidman C; Semsarian C
J Med Genet; 2005 Oct; 42(10):e59. PubMed ID: 16199542
[TBL] [Abstract][Full Text] [Related]
34. Molecular etiology of idiopathic cardiomyopathy in Asian populations.
Kimura A; Ito-Satoh M; Hayashi T; Takahashi M; Arimura T
J Cardiol; 2001; 37 Suppl 1():139-46. PubMed ID: 11433818
[TBL] [Abstract][Full Text] [Related]
35. Genetics of hypertrophic cardiomyopathy: A review of current state.
Sabater-Molina M; Pérez-Sánchez I; Hernández Del Rincón JP; Gimeno JR
Clin Genet; 2018 Jan; 93(1):3-14. PubMed ID: 28369730
[TBL] [Abstract][Full Text] [Related]
36. The dilemma of genotype positive-phenotype negative hypertrophic cardiomyopathy.
Sylvester J; Seidenberg P; Silvis M
Curr Sports Med Rep; 2014; 13(2):94-9. PubMed ID: 24614422
[TBL] [Abstract][Full Text] [Related]
37. [Hypertrophic cardiomyopathy].
Bundgaard H; Havndrup O; Høst U; Kelbaek H
Ugeskr Laeger; 1998 Sep; 160(38):5478-83. PubMed ID: 9763919
[TBL] [Abstract][Full Text] [Related]
38. The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
Brouwer WP; van Dijk SJ; Stienen GJ; van Rossum AC; van der Velden J; Germans T
Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848
[TBL] [Abstract][Full Text] [Related]
39. Hypertrophic cardiomyopathy in childhood.
Maron BJ
Pediatr Clin North Am; 2004 Oct; 51(5):1305-46. PubMed ID: 15331286
[TBL] [Abstract][Full Text] [Related]
40. Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy.
Wang J; Wang Y; Zou Y; Sun K; Wang Z; Ding H; Yuan J; Wei W; Hou Q; Wang H; Liu X; Zhang H; Ji Y; Zhou X; Sharma RK; Wang D; Ahmad F; Hui R; Song L
Eur J Heart Fail; 2014 Sep; 16(9):950-7. PubMed ID: 25132132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
